These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6095344)

  • 61. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
    Huidobro-Toro JP; Parada S
    Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of selective opioid antagonists on butorphanol-induced feeding.
    Levine AS; Grace M; Portoghese PS; Billington CJ
    Brain Res; 1994 Feb; 637(1-2):242-8. PubMed ID: 8180802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Central oxytocin receptor stimulation attenuates the orexigenic effects of butorphanol tartrate.
    Olszewski PK; Klockars OA; Klockars A; Levine AS
    Neuroreport; 2016 Sep; 27(14):1012-7. PubMed ID: 27471903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
    Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
    J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bimodal effect of neuropeptide Y on feeding, and its antagonism by receptor blocking agents in rats.
    Borisova EV; Kadar T; Telegdy G
    Acta Physiol Hung; 1991; 78(4):301-8. PubMed ID: 1668706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Butorphanol tartrate (stadol): a review.
    Vogelsang J; Hayes SR
    J Post Anesth Nurs; 1991 Apr; 6(2):129-35. PubMed ID: 1848891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Opioid antagonists and butorphanol dependence.
    Jaw SP; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1993 Mar; 44(3):497-500. PubMed ID: 8383850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration.
    Kirkham TC
    Physiol Behav; 1990 Mar; 47(3):419-26. PubMed ID: 2163057
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression.
    Tanaka S; Fan LW; Tien LT; Park Y; Liu-Chen LY; Rockhold RW; Ho IK
    J Neurosci Res; 2005 Oct; 82(2):255-63. PubMed ID: 16130146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 74. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE; Shiotsu G; Stein L
    Brain Res; 1991 Apr; 545(1-2):8-16. PubMed ID: 1677606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection.
    Dube MG; Horvath TL; Leranth C; Kalra PS; Kalra SP
    Physiol Behav; 1994 Oct; 56(4):811-3. PubMed ID: 7528433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 78. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lesions of the globus pallidus and striatum attenuate ketocyclazocine-induced feeding.
    Gosnell BA; Morley JE; Levine AS
    Physiol Behav; 1984 Sep; 33(3):349-55. PubMed ID: 6096900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A; Sevarino K; McCance-Katz E; Feingold A
    Pharmacol Biochem Behav; 2002; 71(1-2):85-96. PubMed ID: 11812511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.